VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 28 filers reported holding VASCULAR BIOGENICS LTD in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $15,398 | -69.2% | 128,318 | -60.1% | 0.00% | – |
| Q3 2022 | $50,000 | -91.4% | 321,876 | -11.4% | 0.00% | – |
| Q2 2022 | $584,000 | +138.4% | 363,135 | +150.3% | 0.00% | – |
| Q1 2022 | $245,000 | -24.4% | 145,096 | -11.6% | 0.00% | – |
| Q4 2021 | $324,000 | -49.8% | 164,104 | -48.0% | 0.00% | – |
| Q3 2021 | $646,000 | +14.7% | 315,313 | +33.8% | 0.00% | – |
| Q2 2021 | $563,000 | +310.9% | 235,651 | +244.0% | 0.00% | – |
| Q1 2021 | $137,000 | +522.7% | 68,500 | +480.5% | 0.00% | – |
| Q4 2020 | $22,000 | +57.1% | 11,800 | +10.3% | 0.00% | – |
| Q1 2020 | $14,000 | -6.7% | 10,700 | -32.2% | 0.00% | – |
| Q4 2018 | $15,000 | -50.0% | 15,776 | -15.6% | 0.00% | – |
| Q3 2018 | $30,000 | -14.3% | 18,684 | +18.2% | 0.00% | – |
| Q2 2018 | $35,000 | -80.9% | 15,802 | -80.1% | 0.00% | – |
| Q1 2018 | $183,000 | +128.8% | 79,557 | +604.0% | 0.00% | – |
| Q4 2017 | $80,000 | +29.0% | 11,300 | -0.1% | 0.00% | – |
| Q1 2017 | $62,000 | – | 11,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,593,286 | $5,108,000 | 1.37% |
| Ikarian Capital, LLC | 790,838 | $1,558,000 | 0.23% |
| Telemetry Investments, L.L.C. | 70,000 | $138,000 | 0.18% |
| PVG ASSET MANAGEMENT CORP | 12,365 | $24,359,000 | 0.09% |
| DLD Asset Management, LP | 425,000 | $837,000 | 0.04% |
| Phoenix Holdings Ltd. | 1,020,000 | $2,009,000 | 0.03% |
| Spectrum Planning & Advisory Services Inc. | 16,000 | $32,000 | 0.03% |
| ARK Investment Management | 1,330,206 | $2,621,000 | 0.01% |
| Harel Insurance Investments & Financial Services Ltd. | 194,000 | $382,000 | 0.01% |
| Total Clarity Wealth Management, Inc. | 4,000 | $8,000 | 0.00% |